Ftse Mib
36.471,75
0,12%
DAX
21.732,05
0,01%
S&P 500
6.040,53
-0,50%
NASDAQ
19.627,44
-0,28%
Bitcoin
102.149,32
-0,26%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Allakos Inc (ALLK) Allakos Inc (ALLK) Notizie

Allakos Inc

ALLK
0,238
-0,0061 (-2,50%)
01 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/1/202513:07EDGAR2Form 8-K - Current report
27/1/202513:05EDGAR2Form 8-K - Current report
27/1/202513:00GLOBEAllakos Announces Topline Results from its Phase 1 Trial of..
13/1/202522:07EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/12/202422:15PRNUSKuehn Law Encourages Investors of Allakos Inc. to Contact..
10/12/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202422:25EDGAR2Form 144 - Report of proposed sale of securities
06/12/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202421:57EDGAR2Form 144 - Report of proposed sale of securities
04/12/202422:23EDGAR2Form 144 - Report of proposed sale of securities
18/11/202422:45EDGAR2Form 8-K - Current report
06/11/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:07EDGAR2Form 8-K - Current report
10/10/202422:07EDGAR2Form 8-K - Current report
10/10/202422:04EDGAR2Form 8-K - Current report
10/10/202422:02GLOBEAllakos Announces Phase 1 Trial Results of Subcutaneous..
12/9/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202421:51EDGAR2Form 144 - Report of proposed sale of securities
10/9/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202422:29EDGAR2Form 144 - Report of proposed sale of securities
06/9/202421:46EDGAR2Form 144 - Report of proposed sale of securities
16/8/202414:00EDGAR2Form 8-K - Current report
07/8/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202422:06EDGAR2Form 8-K - Current report
07/8/202422:02GLOBEAllakos Provides Business Update and Reports Second Quarter..
25/6/202422:02GLOBEAllakos Announces Positive Results from its Ongoing Phase 1..
10/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202421:43EDGAR2Form 144 - Report of proposed sale of securities
06/6/202422:14EDGAR2Form 144 - Report of proposed sale of securities
29/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202413:20EDGAR2Form 8-K - Current report
28/5/202413:15EDGAR2Form 8-K - Current report
28/5/202413:02GLOBEAllakos Announces First Patient Dosed in Phase 1 Trial of..
09/5/202423:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:06EDGAR2Form 8-K - Current report
09/5/202422:02GLOBEAllakos Provides Business Update and Reports First Quarter..
14/3/202421:02GLOBEAllakos Provides Business Update and Reports Fourth Quarter..
07/3/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:22EDGAR2Form 144 - Report of proposed sale of securities
04/3/202423:52EDGAR2Form 144 - Report of proposed sale of securities
26/2/202413:05EDGAR2Form 8-K - Current report
26/2/202413:02GLOBEAllakos Presents Preclinical Data Highlighting Inhibition of..
21/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 0,24 Min: 0,2375 Max: 0,2643
Chiusura: 0,2441

La tua Cronologia

NASDAQ
ALLK
Allakos
NASDAQ
IBBQ
Invesco Nasdaq Biotechno...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci